EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Pulmonary Artery Sarcoma Study: A Multi-Centre European Society of Thoracic Surgeons Working Group Evaluating Diagnosis, Treatment, and Outcomes

Olivia Lauk, Bianca Battilana, Ulrike Held iD, Claudia Lourenço Rodrigues, Martina Haberecker iD, Kathrin Chiffi, Tom Verbelen iD, Marc de Perrot, Bedrettin Yildizeli, Lanuti Michael, Bernhard Moser iD, Stefan Schwarz und 3 weitere

European Journal of Cardio-Thoracic Surgery · 04.06.2026 · 68 (6)

DOI: 10.1093/ejcts/ezag133 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 27.03.2026. Verfasst von Olivia Lauk und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, University Hospital Zurich, Zurich, 8091, Switzerland. Hauptthemen laut MEDLINE: Sarcoma, Pulmonary Artery, Vascular Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Pulmonary artery sarcoma (PAS) is a rare and aggressive malignancy often mimicking pulmonary embolism, leading to diagnostic delays and poor outcomes. This study aims to describe the clinical characteristics, diagnostic pathways, treatment modalities, and outcomes of PAS patients in a multicentre cohort.

Methods

This retrospective cohort study included patients from 7 institutions between 1994 and 2024. Clinical, radiological, histological, and treatment data were collected via a standardized REDCap-based platform. All patients underwent either multimodal treatment or single therapy approach, including systemic therapy, surgery, and/or radiotherapy. Kaplan–Meier survival analysis and log-rank testing were performed to assess overall survival (OS) and progression-free survival (PFS).

Results

84 patients from 7 international centres were analysed. The mean age was 54.4 years, and 43.8% of patients were female. The most common presenting symptoms were dyspnoea (81.2%) and chest pain (50.0%). Pulmonary embolism was the most frequent initial misdiagnosis (49.1%). Histologically, PAS was diagnosed in 46 cases. Tumours were bilateral in 58.1% of patients with surgery only. Most commonly, endarterectomy was performed in 59.5%. After a median follow-up time of 39 months, 19 were excluded as they either had no treatment information or received monotherapy only. Additionally, 11 patients were excluded due to missing date of diagnosis and 17 due to missing overall follow-up date. There was moderate evidence that OS differed between treatment groups (75th quantile: 34 months for multimodal [95% CI, 26 to not reached] vs 11 months for surgery only [95% CI, 7-21]; log-rank P = .022). There was no evidence that PFS differed between treatment groups (median 19 months for multimodal [95% CI, 14-39] vs 16 months surgery only [95% CI, 11-21]; log-rank P = .69).

Conclusions

This study represents the largest reported PAS cohort to date and underscores the diagnostic challenges and poor prognosis associated with this disease. Our findings offer evidence that multimodal treatment provides significant prognostic benefits. However, further prospective studies are warranted to establish standardized diagnostic and therapeutic protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaPulmonary ArteryVascular NeoplasmsHumansFemaleMiddle AgedRetrospective StudiesMaleAgedAdultEuropeTreatment Outcome

Stichwörter der Autor:innen

multimodal therapyoverall survivalprogression-free survivalpulmonary artery sarcomasurgery

Autor:innen und Institutionen

  • Department of Thoracic Surgery, University Hospital Zurich, Zurich, 8091, Switzerland.
  • Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, 8057, Switzerland.
  • Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, 8091, Switzerland.
  • Department of Cardiac Surgery, University Hospital Leuven, Leuven, 3000, Belgium.
  • Department of Thoracic Surgery, University of Toronto, Toronto, ON M5G 2C4, Canada.
  • Department of Thoracic Surgery, Marmara University School of Medicine, Istanbul, 34899, Turkey.

ORCID-Profile: Ulrike Held, Martina Haberecker, Tom Verbelen, Bernhard Moser, René Horsleben Petersen, Isabelle Opitz

Förderung

  • Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland

Zitieren

APA

Lauk, O., Battilana, B., Held, U., Rodrigues, C. L., Haberecker, M., Chiffi, K., Verbelen, T., de Perrot, M., Yildizeli, B., Michael, L., Moser, B., Schwarz, S., Awada, H. N., Petersen, R. H., & Opitz, I. (2026). Pulmonary Artery Sarcoma Study: A Multi-Centre European Society of Thoracic Surgeons Working Group Evaluating Diagnosis, Treatment, and Outcomes. European Journal of Cardio-Thoracic Surgery, 68(6). https://doi.org/10.1093/ejcts/ezag133

Vancouver

Lauk O, Battilana B, Held U, Rodrigues CL, Haberecker M, Chiffi K, et al. Pulmonary Artery Sarcoma Study: A Multi-Centre European Society of Thoracic Surgeons Working Group Evaluating Diagnosis, Treatment, and Outcomes. European Journal of Cardio-Thoracic Surgery. 2026;68(6). doi:10.1093/ejcts/ezag133

BibTeX
@article{Lauk2026,
  author = {Lauk, Olivia and Battilana, Bianca and Held, Ulrike and Rodrigues, Claudia Lourenço and Haberecker, Martina and Chiffi, Kathrin and Verbelen, Tom and de Perrot, Marc and Yildizeli, Bedrettin and Michael, Lanuti and Moser, Bernhard and Schwarz, Stefan and Awada, Hussein Nasser and Petersen, René Horsleben and Opitz, Isabelle},
  title = {Pulmonary Artery Sarcoma Study: A Multi-Centre European Society of Thoracic Surgeons Working Group Evaluating Diagnosis, Treatment, and Outcomes},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2026},
  volume = {68},
  number = {6},
  doi = {10.1093/ejcts/ezag133}
}
Kostenlos starten →